Choose your country to see the products for your location

News Archive

New Customs Regulations Outside EU

We would like to remind our non-EU customers who order directly from MRC Holland that we are required to add a surcharge of €0.01 on Sample DNAs (SDs) that are included as accessory items with selected MLPA assays.

Breast Cancer Awareness Month

It is estimated 1 in every 8 women will develop breast cancer in their lifetime, of which 5 to 10 percent will be hereditary. Understanding breast cancer risk and early detection are crucial to provide the best care to patients and at-risk individuals. At MRC Holland, we proudly offer a wide range of assays to help with identifying hereditary breast cancer and at-risk individuals.

Wanted: Positive DNA Samples

MRC Holland is looking for positive samples to be used in testing and developing of our products

MRC Holland Prices in 2024

Effective from 1 January 2024, we will be implementing a price increase of approximately 8% on most of our products.

SMA Awareness Month

August is SMA Awareness Month! Spinal Muscular Atrophy (SMA) is a neuromuscular disease where the body loses control over the muscle movements. Early detection and treatment of SMA are vital for improved outcomes.

Glioblastoma Awareness Day

Today is Glioblastoma Awareness Day, highlighting the need for improved treatment options for this aggressive type of brain cancer.

Introducing Our digitalMLPA Data Demo Sets: Explore the Potential of SALSA® digitalMLPA™ Probemixes

We are excited to announce the release of our comprehensive digitalMLPA data sets, showcasing sample data from various SALSA® digitalMLPA™ applications: D001 Hereditary Cancer, D006 Multiple Myeloma and D007 Acute Lymphoblastic Leukemia.

Research Highlight: New Genetic Scoring Guide for B-ALL Using SALSA® digitalMLPA™ Probemix D007 Acute Lymphoblastic Leukemia

In a recent research article published in the British Journal of Cancer, Bedics et al. developed a new B-ALL classifier using SALSA digitalMLPA Probemix D007 Acute Lymphoblastic Leukemia.

Improved: SALSA MLPA Probemix ME029 FMR1-AFF2 - Changes to Content and Protocol

We are glad to inform you that we have released an improved version of SALSA® MLPA® Probemix ME029 FMR1-AFF2, accompanied by a new product-specific protocol.

New: SALSA MLPA Probemix ME053 BRCA1-BRCA2-RAD51C

We are glad to announce the launch of ME053 BRCA1-BRCA2-RAD51C.

Stay in Touch

Join our mailing list to receive the latest information about our products, technologies and website.

Sign in

Don't have an account? Create one

Forgot password?

Select Your Country

Choose your country to see the products for your location